Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,334 warrant series at 1,058 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Underwriters' (Representative's) Warrants — April 2025 IPO | $2.66 | $10.9M | 20-F, Apr 30, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| Company Pre-Funded Warrants (issued in respect of Mentari Pre-Funded Warrants, Mentari pre-closing financing) | $17.50 | $10.9M | 8-K, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| InMed common share warrants outstanding per 10-Q warrant table (September 30, 2026) — undecomposed aggregate | $17.50 | $10.9M | 10-Q, Nov 3, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Paratari Holding LLC warrant (Mentari warrant issued December 31, 2025, converted into Company Warrant at merger) | $17.50 | $10.9M | 424B3, Oct 1, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Legacy ReShape warrants (aggregate) | $1.54 | $10.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (H.C. Wainwright, December 2024 PIPE) | $2.51 | $10.8M | 20-F, Jun 22, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Private Warrants (former NCAC private placement warrants) | $2.51 | $10.8M | 20-F, Jun 22, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Public Warrants (former NCAC public warrants, PBMWW) | $2.51 | $10.8M | 20-F, Jun 22, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series A Warrants (December 2024 PIPE) | $2.51 | $10.8M | 20-F, Jun 22, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B Warrants (December 2024 PIPE) | $2.51 | $10.8M | 20-F, Jun 22, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Consultant Warrants — First Tranche ($3.00) | $1.42 | $10.8M | 424B3, Jul 28, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant Warrants — Second Tranche ($6.00) | $1.42 | $10.8M | 424B3, Jul 28, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Palladium other warrants (unspecified series) | $1.42 | $10.8M | 424B3, Jul 28, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series H-7 Warrants | $1.42 | $10.8M | 424B3, Jul 28, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series I Investor Warrants | $1.42 | $10.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series I Placement Agent Warrants | $1.42 | $10.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series K Investor Warrants | $1.42 | $10.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series K Placement Agent Warrants | $1.42 | $10.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Waiver Warrants | $1.42 | $10.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Additional Warrants issued in liquidity transactions (two counterparties) | $0.5613 | $10.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Avalon Private Warrants | $0.5613 | $10.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Avalon Public Warrants (BENFW) | $0.5613 | $10.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Yorkville Warrant – First Closing (August 6, 2024) | $0.5613 | $10.8M | 10-K, Jun 30, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Yorkville Warrant – Second Closing (November 13, 2024) | $0.5613 | $10.8M | 10-K, Jun 30, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Acuitas PIPE Warrant (Aug 2022) | $0.9953 | $10.7M | 10-K, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| August 2025 Public Warrants (BIVIW, $2.50) | $0.9953 | $10.7M | 10-K, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| August 2025 Underwriter Warrants ($2.50) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Avenue Warrants (Nov 2021 loan warrants) | $0.9953 | $10.7M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| March 2024 Common Warrants ($150.00) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| March 2024 Placement Agent Warrants ($125.00) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| November 2026 Common Warrants ($1.70) | $0.9953 | $10.7M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| November 2026 Pre-Funded Warrants | $0.9953 | $10.7M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 21, 2024 Placement Agent Warrants ($18.75) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 21, 2024 Private Placement Warrants ($13.70) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 23, 2024 Placement Agent Warrants ($28.125) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 23, 2024 Private Placement Warrants ($21.20) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 28, 2024 Placement Agent Warrants ($35.375) | $0.9953 | $10.7M | S-1, Jul 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2024 Common Warrants ($15.30) | $0.9953 | $10.7M | 10-K, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2024 Placement Agent Warrants ($19.10) | $0.9953 | $10.7M | 10-K, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| 2022 Inducement Warrants | $0.5933 | $10.6M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2022 Purchase Warrants | $0.5933 | $10.6M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2023 Purchase Warrants (Common Warrants) | $0.5933 | $10.6M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Unit Purchase Options (IPO and December 2021 private placement) | $0.5933 | $10.6M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – August 2026 ($0.50, three-year) | $0.3223 | $10.6M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – December 2025 ($1.00, five-year) | $0.3223 | $10.6M | 10-K, Apr 8, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – July 2025 ($1.00, through July 2028) | $0.3223 | $10.6M | 10-K, Apr 8, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – June 2024 ($0.50, through June 30, 2027) | $0.3223 | $10.6M | 10-K, Apr 8, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – May 2026 ($0.50, three-year) | $0.3223 | $10.6M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – September 2024 ($0.50, through September 10, 2027) | $0.3223 | $10.6M | S-1/A, Jul 31, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| Consultant warrants – September 2024 ($1.00, through September 10, 2027) | $0.3223 | $10.6M | S-1/A, Jul 31, 2025Dilution tabAs of Nov 14, 2026 |
PFAIPinnacle Food Group Limited Class A Common Shares$2.66Last price
Underwriters' (Representative's) Warrants — April 2025 IPO
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.9M
MTRIMentari Therapeutics, Inc.$17.50Last price
Company Pre-Funded Warrants (issued in respect of Mentari Pre-Funded Warrants, Mentari pre-closing financing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.9M
MTRIMentari Therapeutics, Inc.$17.50Last price
InMed common share warrants outstanding per 10-Q warrant table (September 30, 2026) — undecomposed aggregate
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.9M
MTRIMentari Therapeutics, Inc.$17.50Last price
Paratari Holding LLC warrant (Mentari warrant issued December 31, 2025, converted into Company Warrant at merger)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.9M
HINDVyome Holdings, Inc.$1.54Last price
Legacy ReShape warrants (aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
PBMPsyence Biomedical Ltd.$2.51Last price
Placement Agent Warrants (H.C. Wainwright, December 2024 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
PBMPsyence Biomedical Ltd.$2.51Last price
Private Warrants (former NCAC private placement warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
PBMPsyence Biomedical Ltd.$2.51Last price
Public Warrants (former NCAC public warrants, PBMWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
PBMPsyence Biomedical Ltd.$2.51Last price
Series A Warrants (December 2024 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
PBMPsyence Biomedical Ltd.$2.51Last price
Series B Warrants (December 2024 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Consultant Warrants — First Tranche ($3.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Consultant Warrants — Second Tranche ($6.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Palladium other warrants (unspecified series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Series H-7 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Series I Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Series I Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Series K Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Series K Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
FABCFabric.AI, Inc.$1.42Last price
Waiver Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BENFBeneficient$0.5613Last price
Additional Warrants issued in liquidity transactions (two counterparties)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BENFBeneficient$0.5613Last price
Avalon Private Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BENFBeneficient$0.5613Last price
Avalon Public Warrants (BENFW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BENFBeneficient$0.5613Last price
Yorkville Warrant – First Closing (August 6, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BENFBeneficient$0.5613Last price
Yorkville Warrant – Second Closing (November 13, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.8M
BIVIBioVie Inc.$0.9953Last price
Acuitas PIPE Warrant (Aug 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
August 2025 Public Warrants (BIVIW, $2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
August 2025 Underwriter Warrants ($2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
Avenue Warrants (Nov 2021 loan warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
March 2024 Common Warrants ($150.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
March 2024 Placement Agent Warrants ($125.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
November 2026 Common Warrants ($1.70)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
November 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
October 21, 2024 Placement Agent Warrants ($18.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
October 21, 2024 Private Placement Warrants ($13.70)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
October 23, 2024 Placement Agent Warrants ($28.125)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
October 23, 2024 Private Placement Warrants ($21.20)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
October 28, 2024 Placement Agent Warrants ($35.375)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
September 2024 Common Warrants ($15.30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BIVIBioVie Inc.$0.9953Last price
September 2024 Placement Agent Warrants ($19.10)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.7M
BFRIBiofrontera Inc.$0.5933Last price
2022 Inducement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
BFRIBiofrontera Inc.$0.5933Last price
2022 Purchase Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
BFRIBiofrontera Inc.$0.5933Last price
2023 Purchase Warrants (Common Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
BFRIBiofrontera Inc.$0.5933Last price
Unit Purchase Options (IPO and December 2021 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – August 2026 ($0.50, three-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – December 2025 ($1.00, five-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – July 2025 ($1.00, through July 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – June 2024 ($0.50, through June 30, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – May 2026 ($0.50, three-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – September 2024 ($0.50, through September 10, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
MOBQMobiquity Technologies, Inc.$0.3223Last price
Consultant warrants – September 2024 ($1.00, through September 10, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$10.6M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 18, 2026.
Read from 2,083 dilution snapshots. 4,882 of 5,334 series state an exercise price and 3,363 an expiry date. 292 record when exercise begins; that count grows as companies are re-extracted. 628 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.